An International Study on Pediatric Patients With Rare Tumors.

Launched by AZIENDA OSPEDALIERA DI PADOVA · Jul 16, 2025

Keywords

ClinConnect Summary

This clinical trial, called the PARTNER study, is an international research project focused on children and teenagers who have very rare types of tumors. These tumors include a variety of unusual cancers affecting areas like the skin, pancreas, thyroid, and other parts of the body. The goal of the study is to learn more about these rare cancers by observing how patients are diagnosed and treated in different countries, helping doctors understand them better and improve care in the future.

Children and adolescents from birth up to 18 years old who have been diagnosed with one of these rare tumors, whether for the first time or if the tumor has come back, may be eligible to join. To take part, patients and their parents or guardians need to agree to participate by signing a consent form. If you join, you won’t be given any new treatments as part of the study; instead, the researchers will collect information about your diagnosis, treatment, and outcomes to help build knowledge about these rare conditions. This study is currently open and welcoming participants from many locations around the world.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
• • Written informed consent from the patient and/or the parent/legal guardian
• Exclusion Criteria:
• • Absence of Written informed consent from the patient and/or the parent/legal guardian